Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Completed 36Terminated 12Recruiting 12Active not recruiting 8Unknown 5Withdrawn 4Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4CNS 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Breast 1

Conditions

Prostatic Neoplasms 3Neoplastic Cells, Circulating 1Castrate-resistant Metastatic Prostate Cancer 1

Interventions

pembrolizumab 19Docetaxel 16Magnetic Resonance Spectroscopy 14Prednisone 13Radiotherapy 11bicalutamide 10Leuprolide 10Abiraterone Acetate 9Radiosurgery 8Cyclophosphamide 8Biopsy 8avelumab 7atezolizumab 6Specimen Handling 6Interleukin-2 6Gemcitabine 6Bevacizumab 6Androgen Antagonists 6tremelimumab 5gallium 68 PSMA-11 5apalutamide 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Surveys and Questionnaires 5Sunitinib 5Paclitaxel 5Metformin 5Injections 5Goserelin 5Cisplatin 5ALT-803 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × cabazitaxel × Genitourinary × Clear all
NCT03110588 2020-10-19

Phase I Trial of PACE for Metastatic Prostate Cancer

University of Alabama at Birmingham

Phase 1 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT02621190 2016-08-17

CARVE

Erasmus Medical Center

Phase 2 Withdrawn
Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT01981668 2014-03-19

The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation

Nova Scotia Cancer Centre

Phase 1 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT01750866 2013-10-16

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Case Comprehensive Cancer Center

Phase 2 Withdrawn
Genitourinary

Castrate-resistant Metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡